Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children
Clinical trial NCT01001169 · COMPLETED
Trial details
- NCT number
- NCT01001169
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2010-05-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.